Calibre Scientific UK Relocates to State-Of-The-Art Facility in the Advanced Manufacturing Park, Sheffield
LOS ANGELES, July 07, 2022 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the relocation of three key UK business units—BioServUK, Molecular Dimensions, and Protein Ark—from the Innovation Centre to the Advanced Manufacturing Park (Sheffield, UK). Situated alongside other market leaders, this customized facility will include hi-tech laboratories for research, development, and product manufacture, efficiently designed warehouse space, and innovative employee workspaces to foster collaboration and communication.
The address and contact details of the new facility are:
Calibre Scientific UK
Unit 5a, R-evolution
The Advanced Manufacturing Park
Selden Way
Rotherham
S60 5XA
UK
Tel: +44 (0) 114 224 2257
As part of Calibre Scientific’s ongoing commitment to business development, customer experience, and operational efficiency, the updated facility will bring significant growth and expansion opportunities, ensuring Calibre Scientific remains at the forefront of business operations and scientific excellence in the UK.
“Relocation to the Advanced Manufacturing Park is the next exciting chapter in the ongoing expansion and evolution of Calibre Scientific within the UK,” said Andy Wright, General Manager, Calibre Scientific UK. “It allows us to continue our mission of creating a better tomorrow by solving life science challenges, today.”
About Calibre Scientific
Calibre Scientific is a diversified global provider of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics, industrial, and biopharmaceutical communities. Calibre Scientific owns a portfolio of life science and diagnostic companies that have an unrivaled ability to address the unique challenges of their respective markets. Our global reach extends to over 175 countries, empowering customers all over the world. Headquartered in Los Angeles, California, Calibre Scientific continues to expand its product offering and global footprint to laboratories across a wide array of verticals and geographies.
For more information, visit www.calibrescientific.com, or contact press@calibrescientific.com.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Hexagon Purus ASA: Minutes of Annual General Meeting16.4.2024 12:50:00 CEST | Press release
The annual general meeting of Hexagon Purus ASA was held today, 16 April 2024 in Oslo, Norway. All proposals on the agenda were adopted as proposed. Complete minutes of the annual general meeting are attached to this release and are also available on www.hexagonpurus.com. For more information Mathias Meidell, IR Director, Hexagon Purus ASA Telephone: +47 909 82 242 | mathias.meidell@hexagonpurus.com About Hexagon Purus ASA Hexagon Purus enables zero emission mobility for a cleaner energy future. The company is a world leading provider of hydrogen Type 4 high-pressure cylinders and systems, battery systems and vehicle integration solutions for fuel cell electric and battery electric vehicles. Hexagon Purus' products are used in a variety of applications including light, medium and heavy-duty vehicles, buses, ground storage, distribution, refueling, maritime, rail and aerospace. Learn more at www.hexagonpurus.com and follow @HexagonPurus on Twitter and LinkedIn. This information is subje
European Energy A/S: Optional Redemption Notice to the holders of bonds issued by European Energy A/S16.4.2024 12:37:55 CEST | Press release
Company announcement 10/2024 (16.04.2024) NOT INTENDED FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES. NOT INTENDED FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO ANY PERSON IN ANY JURISDICTION WHERE RELEASE, PUBLICATION OR DISTRIBUTION TO SUCH PERSON IS RESTRICTED BY ANY LAW OR REGULATION APPLICABLE IN SUCH JURISDICTION. THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL OR ISSUE OR INVITATION TO PURCHASE OR SUBSCRIBE FOR, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES. Reference is made to: (i) the terms and conditions dated 7 September 2021 (the “2025 Senior Conditions”) for the EUR 300,000,000 Senior Unsecured Green Bonds due 2025 issued by European Energy A/S (the “Issuer”) with ISIN DK0030494505 (the “2025 Senior Bonds”); (ii) the terms and conditions dated 6 September 2022 (the “2026 Senior Conditions”), as supplemented by the addendum dated 24 January 2023, for the EUR 150,000,000 Senior Unsecure
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 202416.4.2024 12:24:17 CEST | Press release
Company Announcement Net sales of DARZALEX® in the first quarter of 2024 totaled USD 2,692 millionGenmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen) COPENHAGEN, Denmark; April 16, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX® (daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under the tradename DARZALEX FASPRO® in the U.S.), as reported by Johnson & Johnson were USD 2,692 million in the first quarter of 2024. Net trade sales were USD 1,464 million in the U.S. and USD 1,228 million in the rest of the world. Genmab receives royalties on the worldwide net sales of DARZALEX, both the intravenous and SC products, under the exclusive worldwide license to Janssen to develop, manufacture and commercialize daratumumab. About Genmab Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the
NetBet Casino joins forces with Play'n Go16.4.2024 12:22:25 CEST | Press release
COPENHAGEN, Denmark, April 16, 2024 (GLOBE NEWSWIRE) -- NetBet Denmark has reached a deal with the leading online software provider Play'n Go. This agreement will see the quantity of games available to Danish players expanded as a result of the addition of several Play’n Go titles. Play'n Go has become a pillar of the online gaming industry since its founding in 2005. Most recently, the company scored a hat-trick of award wins at the 5Star iGaming Media Starlet Awards, claiming the prestigious titles of Slots Provider of the Year, Mobile Supplier of the Year, and Game of the Year. NetBet Denmark’s customers can now experience the thrilling excitement of a wide variety of Play’n Go slot games, with the flagship titles including Book of Dead, Legacy of Dead and Reactoonz - each one crafted to provide plenty of entertainment. NetBet Denmark’s PR manager, Claudia Georgevici, said: "At NetBet, we understand the widespread appeal of slots – they offer players a unique experience while being
NetBet Casino slår sig sammen med Play'n Go16.4.2024 12:22:25 CEST | pressemeddelelse
COPENHAGEN, Denmark, April 16, 2024 (GLOBE NEWSWIRE) -- NetBet Danmark har indgået en aftale med den førende online softwareudbyder Play'n Go. Aftalen betyder, at deres udvalg af spil, som er tilgængelige for danske spillere, udvides med flere Play'n Go-spil. Play'n Go er blevet en af grundpillerne i onlinespilbranchen siden deres grundlæggelse i 2005. Senest har virksomheden vundet et hattrick af priser ved 5Star iGaming Media Starlet Awards med de prestigefyldte titler som årets spilleautomatudbyder, årets mobiludbyder og årets spil. NetBet Danmarks spillere kan nu opleve spændingen fra et bredt udvalg af Play'n Go spilleautomater, med flagskibstitler som Book of Dead, Legacy of Dead og Reactoonz - hver især skabt til at give masser af underholdning. NetBet Danmarks PR-manager, Claudia Georgevici, udtaler: "Hos NetBet forstår vi spillemaskinernes store tiltrækningskraft - de giver spillerne en unik oplevelse, samtidig med at de er nemme at spille. Play'n Go har skabt et stort udvalg